
How to Vet an “Automation-Enabled” Domestic Supplier
Reshoring pitches now lead with automation. Six diligence questions that separate a genuinely automated supplier from a demo cell.
Read more →The B2B Manufacturing Industry Directory

Reshoring pitches now lead with automation. Six diligence questions that separate a genuinely automated supplier from a demo cell.
Read more →
The 100% Section 232 duty on patented pharmaceuticals began July 31, 2026, with a second cohort starting September 29. What API suppliers face.
Read more →
The first-ever Section 338 action put a 50% duty on about $20 billion of Canadian goods. A three-day pause expired without a deal and the duty took effect …
Read more →
Manufacturing PMI hit 55.6% in July 2026 as backlogs jumped and supplier deliveries slowed again. A playbook for the Q4 capacity talk.
Read more →
Tariff policy promised a wave of US reshoring. Trade data instead shows a lot of production relocating to other Asian and nearshore markets rather than coming …
Read more →
Tariffs get the headlines, but the real ceiling on US reshoring is workforce availability. A buyer's framework for vetting a domestic supplier's labor stability …
Read more →
Reshoring pitches now lead with automation. Six diligence questions that separate a genuinely automated supplier from a demo cell.
Read more →
Manufacturing PMI hit 55.6% in July 2026 as backlogs jumped and supplier deliveries slowed again. A playbook for the Q4 capacity talk.
Read more →
The first-ever Section 338 action put a 50% duty on about $20 billion of Canadian goods. A three-day pause expired without a deal and the duty took effect …
Read more →